Simplex Trading’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$38K | – | 10302 |
|
|
2023
Q2 | $38K | Sell |
1,000
-14,900
| -94% | -$383K | ﹤0.01% | 6119 |
|
|
2023
Q1 | $368K | Buy |
15,900
+9,600
| +152% | +$229K | ﹤0.01% | 3592 |
|
|
2022
Q4 | $165K | Sell |
6,300
-600
| -9% | -$13.3K | ﹤0.01% | 4473 |
|
|
2022
Q3 | $135K | Sell |
6,900
-80,900
| -92% | -$1.62M | ﹤0.01% | 5119 |
|
|
2022
Q2 | $1.53M | Buy |
87,800
+86,800
| +8,680% | +$1.36M | ﹤0.01% | 2148 |
|
|
2022
Q1 | $16K | Sell |
1,000
-1,700
| -63% | -$23.1K | ﹤0.01% | 8496 |
|
|
2021
Q4 | $44K | Buy |
2,700
+2,400
| +800% | +$34.2K | ﹤0.01% | 7436 |
|
|
2021
Q3 | $4K | Hold |
300
| – | – | ﹤0.01% | 9380 |
|
|
2021
Q2 | $4K | Buy |
+300
| New | +$4.8K | ﹤0.01% | 9561 |
|
|
2021
Q1 | – | Sell |
-41
| Closed | -$64K | – | 10362 |
|
|
2020
Q4 | $64K | Buy |
+41
| New | +$619 | ﹤0.01% | 5917 |
|
|
2020
Q3 | – | Sell |
-131
| Closed | -$151K | – | 8744 |
|
|
2020
Q2 | $151K | Buy |
131
+104
| +385% | +$1.43K | ﹤0.01% | 4320 |
|
|
2020
Q1 | $37K | Buy |
27
+13
| +93% | +$154 | ﹤0.01% | 5453 |
|
|
2019
Q4 | $8K | Buy |
+14
| New | +$76 | ﹤0.01% | 6519 |
|
|
2019
Q3 | – | Sell |
-3
| Closed | -$2K | – | 8080 |
|
|
2019
Q2 | $2K | Buy |
3
+1
| +50% | +$15 | ﹤0.01% | 6801 |
|
|
2019
Q1 | $4K | Buy |
+2
| New | +$35 | ﹤0.01% | 6600 |
|
|
2018
Q4 | – | Hold |
0
| – | -$1K | – | 8054 |
|
|
2018
Q3 | – | Sell |
-2
| Closed | -$64 | – | 7247 |
|
|
2018
Q2 | $8K | Sell |
2
-18
| -90% | -$690 | ﹤0.01% | 6487 |
|
|
2018
Q1 | $1K | Sell |
20
-28
| -58% | -$1.02K | ﹤0.01% | 5869 |
|
|
2017
Q4 | $2K | Buy |
48
+3
| +7% | +$131 | ﹤0.01% | 5303 |
|
|
2017
Q3 | $6K | Buy |
45
+34
| +309% | +$2.02K | ﹤0.01% | 4286 |
|
|
2017
Q2 | $8K | Buy |
11
+2
| +22% | +$100 | ﹤0.01% | 4222 |
|
|
2017
Q1 | $3K | Buy |
9
+5
| +125% | +$282 | ﹤0.01% | 5101 |
|
|
2016
Q4 | $2K | Sell |
4
-57
| -93% | -$3.45K | ﹤0.01% | 5171 |
|
|
2016
Q3 | $72K | Sell |
61
-6
| -9% | -$424 | ﹤0.01% | 1805 |
|
|
2016
Q2 | $19K | Buy |
+67
| New | +$4.07K | ﹤0.01% | 2961 |
|
Simplex Trading's KDNY Position: Q3 2023 in Review
Simplex Trading sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 25,538 shares — an estimated $981K sold.
Simplex Trading first reported a position in KDNY in Q2 2015 and held it in 17 quarters. The position peaked at $981K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Simplex Trading reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Simplex Trading sold 25,538 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $981K.
- Simplex Trading first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Simplex Trading's Chinook Therapeutics, Inc. Common Stock position peaked at $981K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.